Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free Dating
Ñompany Maksim-LLC. Ýëåêòðîïðèâîäû. Made and sell.
Popular Articles

FDA Grants Full Approval For SPRYCEL For The Treatment Of Adults With Chronic Myeloid Leukemia
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has granted full approval for SPRYCEL® (dasatinib) for the treatment of adults in all phases of chronic myeloid leukemia (CML) (chronic, accelerated, or myeloid or lymphoid blast phase) with resistance or intolerance to prior therapy including Gleevec®* (imatinib mesylate).
new payday loan lenders
Buy zoloft and forget about depression.
Major Scots Study Tackles Bowel Disease In Kids
Scotland has one of the highest rates in the world of inflammatory bowel disease (IBD) and its incidence is rising among Scots children. Now researchers have begun a major Scotland wide study into IBD - which encompasses Crohn"s disease and ulcerative colitis - which afflicts around 1,000 people under 18 years old in Scotland. Their work - led by the University of Aberdeen - is being supported by a research grant of ÷£182, 235 from the Chief Scientist Office.
News of the day
DeCODE Discovers A Gene Linked To Risk Of Kidney Stones And Osteoporosis
A discovery by scientists at deCODE genetics (Nasdaq: DCGN) and academic colleagues from Iceland, the Netherlands and Denmark has pointed to a common biological mechanism contributing to both kidney stones and decreased bone mineral density (BMD). About 60% of the population carry two copies of a single-letter variation in the human genome (SNP) on chromosome 21, putting them at roughly 65% greater likelihood of developing kidney stones than those who carry no copies. This single variant may thus account for more than a quarter of the incidence of kidney stones, and in women carriers it is also associated with decreased BMD at the hip and spine.
Medical Devices

UT San Antonio Researcher Wins $917,000 From NIH To Study Memory

Every 16 hours, give or take, the brain"s hippocampus makes six to nine thousand new neurons in the dentate gyrus, the portion of the brain which is believed to play a significant role in the preservation of episodic, or autobiographical, memory. But how do those neurons store information? And, more importantly, how do they decide which information to store and which to discard? University of Texas at San Antonio (UTSA) researcher Brian Derrick hopes to soon find out. The UTSA neurobiologist, a member of UTSA"s Department of Biology and its Neurosciences Institute, has won $917,000 in funding from the National Institutes of Health to research these and other related questions. According to Derrick, the key lies in the difference between learning and memory. "Learning is the acquisition of new knowledge," he notes. "Memory is the persistence of learning over time. This kind of memory does not simply involve "what" and "where" events occurred; "when" is also a crucial variable. We believe the continual generation of new neurons in both rats and humans serve as a temporal marker for highly similar memories. Because time also plays a role in memories, the contribution of these new neurons to episodic memory is the focus of this four-year grant." Although memory loss is most commonly associated with aging, it is also symptomatic of more debilitating diseases, including Alzheimer"s disease, Parkinson"s disease and Huntington"s disease, which collectively afflict 9.3 million people around the world. Christi Fish University of Texas at San Antonio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009